C
Curie Co
A life science company that engineers enzymes and marine biomaterials to replace harmful and banned chemicals
About Curie Co
Curie Co operates in the personal care and consumer goods market, focusing on sustainable and safe ingredient solutions. The company specializes in enzyme engineering and recycled marine biomaterials to replace chemicals banned by major retailers like Amazon, Walmart, and Target. Curie Co's proprietary technology ensures that their ingredients are 100% biodegradable and safe for the environment, addressing regulatory bans on harmful substances. The business model revolves around supplying these eco-friendly ingredients to manufacturers of everyday products such as shampoos, lotions, and soaps, without increasing the price point for consumers. Revenue is generated through partnerships and sales to large-scale retailers and manufacturers. Curie Co's team boasts strong expertise in pharmaceutical manufacturing, industrial enzyme engineering, and bioinformatics, positioning the company as a leader in the field. The company aims to become a trusted supplier and world leader in engineered enzymes and biopolymers.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Headquarters
- New York City, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 20.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biomaterials, Industrial Technology, Biotech and Pharma, Hard Tech, DT and LS
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jan 2022 | $12M | $48M | Undisclosed | ↗ |
| GRANTOther financing | Aug 2020 | $1.2M | — | US National Science Foundation | — |
Growth signals
Latest recorded traffic for Curie Co is 1.7K monthly website visits, down 10.5% over the last three months. Curie Co's team declined 41.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A1 investor entered at this stage
Joyance Partners
Other known investors4 additional known investors
Breakout Labs
Cantos Ventures
Small Business Innovation Research
Social Starts
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Curie Co on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Curie Co’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.